apitegromab tirzepatide Scholar Rock (SRRK): High-Stakes Biotech With a Promising Pipeline—But a Pricey Premise Next-Generation Myostatin Inhibitors: Bimagrumab, Trevogrumab,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
















/product/41/5015682/1.jpg?5024)




